We have demonstrated that MMP2 and -9–mediated SDC4 shedding is the underlying mechanism of endothelial glycocalyx damage in DKD and that this pathway is potentially amenable to therapeutic intervention. This evidence concerns the gene SDC4 and diabetic kidney disease.